Home » Medical Devices » Endocrine Testing Market Size, Share, Analysis Report
Endocrinology is a science of the study of Endocrine glands its structure and functions. The Endocrine glands consists of pituitary glands, thyroid glands, adrenal glands and pancreas. The Endocrine glands secrete hormones directly into the main blood stream and help in the normal body functions. The endocrine tests help in detecting the deviations in the secretion of the hormones which is helpful to understand the disorders like infertility, menopause, thyroid dysfunction.
The global opportunity in endocrine testing was worth US$ 6.1 billion. Rising at a CAGR of 8.50% between 2019 and 2025, it is likely to increase to US$ 17.50 billion by 2028.
The major driving factors of Endocrine Testing market are as follows:
• The occurrences of endocrine disorders are increasing these days such as diabetes, thyroid disorders, and infertility.
• The advancement of the technology
• Increasing health care awareness.
The restraints factors of Endocrine testingmarket are as follows:
• The high cost of development of the technology.
The Endocrine Testing market is segmented on the lines of its Test, Diagnostic technology, End User. type like Follicle stimulating hormone(FSH) Human Chorionic Gonadotropin (hCG) Thyroid stimulating Hormone(TSH) Dehydroepiandrosterone sulfate (DHEAS) Prolactin Progesterone Insulin Cortisol Testosterone Estradiol(E2) Luteinizing Hormone (LH). The Endocrine Testing market is segmented on the lines of its Diagnostic Technology as ImmunoassayClinical ChemistryMonoclonal and Polyclonal AntibodyTandem Mass Spectroscopy.
The Endocrine Testing market is segmented on the lines of its End User as
HospitalsPhysicians OfficesHealth Care CentersCommercial Laboratories
The Endocrine Testing market geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geography market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.
This report provides:
1) An overview of the global market for Endocrine Testing and related technologies.
2) Analyses of global market trendsand projections of compound annual growth rates (CAGRs) through 2028.
3) Identifications of new market opportunities and targeted promotional plans for Endocrine Testing market.
4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry.
REPORT SCOPE:
The scope of the report includes a detailed study of global and regional markets for various types of Endocrine Testing market with the reasons given for variations in the growth of the industry in certain regions.
The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Quest Diagnostics, Thermo Fisher Scientific, Siemens Healthcare, Ortho Clinical Diagnostics, bioMerieux, Agilent Technologies, Abbott Laboratories and others. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.
The Top Companies Report is intended to provide our buyers with a snapshot of the industry’s most influential players.
The endocrine testing market is segmented as follows:
Market by Test
• Follicle stimulating hormone(FSH)
• Human Chorionic Gonadotropin (hCG)
• Thyroid Stimulating Hormone(TSH)
• Dehydroepiandrosterone sulfate (DHEAS)
• Prolactin
• Progesterone
• Insulin
• Cortisol
• Testosterone
• Estradiol(E2)
• Luteinizing Hormone (LH)
Market by Diagnostic Technology
• Immunoassay
• Clinical Chemistry
• Monoclonal and Polyclonal Antibody
• Tandem Mass Spectroscopy
Market by End User
• Hospitals
• Physicians Offices
• Health Care Centers
• Commercial Laboratories
Market by Geography
• North America
• Europe
• Asia Pacific
• RoW
Reasons to buy this Report:
1) Obtain the most up to date information available on all active and planned endocrine testingmarket globally.
2) Identify growth segments and opportunities in the industry.
3) Facilitate decision making on the basis of strong historic and forecast of Endocrine Testing market industry and unit capacity data.
4) Assess your competitor’s refining portfolio and its evolution.
Customization:
We can offer you custom research reports as per client’s special requirements.
Below are our new reports:
Cylindrical Power Kerato Refractometer Market
chapter 1 INTRODUCTION
1.1 Key Take Aways
1.2 Report Description
1.3 Markets Covered
1.4 Stakeholders
1.5 Research Methodology
1.5.1 Market Size
1.5.2 Market Share
1.5.3 Key Data Points From Secondary Sources
1.5.4 Key Data Points From Primary Sources
Chapter 2 Executive Summary
2.1 Global Endocrine Testing Market Revenue, by Diagnostic Technologies, 2015 & 2025 (Value %)
2.2 Global Endocrine Testing Market Revenue, by End-User, 2015 & 2025 (US$ Million)
2.3 Global Endocrine Testing Market Revenue, by Tests, 2019 (US$ Million)
2.4 Global Endocrine Testing Market Revenue, by Geography, 2015 & 2025 (US$ Million)
2.5 Global Endocrine Testing Market, 2019 & 2025: Market Snapshot
Chapter 3 Industry Analysis
3.1 Introduction
3.2 Market Dynamics
3.2.1 Drivers
3.2.1.1 Increasing Incidence of diabetic and obese population worldwide
3.2.1.2 Consistent rise in geriatric population Worldwide
3.2.1.3 Technological advancements
3.2.2 Restraints
3.2.2.1 High cost of technology
3.2.2.2 Lack of healthcare awareness in emerging economies
3.2.3 Opportunity
3.2.3.1 Investment Opportunity
3.2.4 Endocrine Testing Market: Porter’s Five Forces Analysis
3.2.5 Market Attractiveness Analysis – Endocrine Testing Market, by Geography, 2015
3.2.6 Competitive Landscape
3.2.6.1 Global Endocrine Testing Market: Market Share, by Key Players, 2015 (%)
3.2.6.2 At Home and Physician Office Endocrine Tests Market Revenue, by Tests, 2015 (US$ Million)
Chapter 4 Market Segmentation – By Tests
4.1 Introduction
4.2 Global Estradiol (E2) Test Market Revenue, 2015-2025 (US$ Mn)
4.3 Global Follicle Stimulating Hormone (FSH) Test Market Revenue, 2015-2025 (US$ Mn)
4.4 Global Human Chorionic Gonadotropin (hCG) Test Market Revenue, 2015-2025 (US$ Mn)
4.5 Global Luteinizing Hormone (LH) Test Market Revenue,2015-2025 (US$ Mn)
4.6 Global Dehydroepiandrosterone sulfate (DHEAS) Test Market Revenue, 2015-2025 (US$ Mn)
4.7 Global Progesterone Test Market Revenue, 2015-2025 (US$ Mn)
4.8 Global Testosterone Test Market Revenue, 2015-2025 (US$ Mn)
4.9 Global Thyroid Stimulating Hormone (TSH) Test Market Revenue, 2015-2025 (US$ Mn)
4.10 Global Prolactin Test Market Revenue, 2015-2025 (US$ Mn)
4.11 Global Cortisol Test Market Revenue, 2015-2025 (US$ Mn)
4.12 Global Insulin Test Market Revenue, 2015-2025 (US$ Mn)
4.13 Global Other Endocrine Tests Market Revenue, 2015-2025 (US$ Mn)
Chapter 5 Market Segmentation – By Diagnostic Technology
5.1 Global Tandem Mass Spectrometry Market Revenue, 2015-2025 (US$ Mn)
5.2 Global Immunoassay Technologies Market Revenue, 2015-2025 (US$ Mn)
5.3 Global Monoclonal and Polyclonal Antibody Technologies Market Revenue, 2015-2025 (US$ Mn)
5.4 Global Sensor Technologies Market Revenue, 2015-2025 (US$ Mn)
5.5 Global Clinical Chemistry Technologies Market Revenue, 2015-2025 (US$ Mn)
5.6 Global Others Technologies Market Revenue, 2015-2025 (US$ Mn)
Chapter 6 Market Segmentation – By End User
6.1 Global Hospitals Market Revenue, 2015-2025 (US$ Mn)
6.2 Global Commercial Laboratories Market Revenue, 2015-2025 (US$ Mn)
6.3 Global Ambulatory Care Centers Market Revenue, 2015-2025 (US$ Mn)
6.4 Global Home Based tests Market Revenue, 2015-2025 (US$ Mn)
6.5 Global Physician Offices Market Revenue, 2015-2025 (US$ Mn)
Chapter 7 Market Segmentation – By Geography
7.1 North America Market Revenue, 2015-2025 (US$ Mn)
7.2 Europe Market Revenue, 2015-2025 (US$ Mn)
7.3 Asia Pacific Market Revenue, 2015-2025 (US$ Mn)
7.4 Rest of the World Market Revenue, 2015-2025 (US$ Mn)
Chapter 8 Recommendations
Chapter 9 Company Profiles
9.1 Abbott Laboratories
9.2 AB Sciex Pte. Ltd.
9.3 Agilent Technologies
9.4 Biomedical Diagnostics
9.5 bioMerieux SA
9.6 Bio-Rad Laboratories, Inc.
9.7 DiaSorin S.p.A.
9.8 F. Hoffmann-La Roche Ltd.
9.9 Laboratory Corporation of America Holdings (LabCorp)
9.10 Ortho-Clinical Diagnostics
9.11 Quest Diagnostics
9.12 Siemens Healthcare GmbH (Siemens AG)
9.13 Sysmex Corporation
9.14 Thermo Fisher Scientific, Inc.
The endocrine testing market is segmented as follows:
Market by Test
• Follicle stimulating hormone(FSH)
• Human Chorionic Gonadotropin (hCG)
• Thyroid Stimulating Hormone(TSH)
• Dehydroepiandrosterone sulfate (DHEAS)
• Prolactin
• Progesterone
• Insulin
• Cortisol
• Testosterone
• Estradiol(E2)
• Luteinizing Hormone (LH)
Market by Diagnostic Technology
• Immunoassay
• Clinical Chemistry
• Monoclonal and Polyclonal Antibody
• Tandem Mass Spectroscopy
Market by End User
• Hospitals
• Physicians Offices
• Health Care Centers
• Commercial Laboratories
Market by Geography
• North America
• Europe
• Asia Pacific
• RoW